Duke University, through the Immune Tolerance Network, is offering a multicenter, Phase III interventional clinical trial examining the efficacy of autologous hematopoietic stem cell transplantation, an emerging therapy for patients with active, treatment-resistant,...
Monash University investigators are in pursuit for a new treatment for multiple sclerosis (MS) that they believe may actually reverse effects of the disease on the brain. They are exploring the use of an experimental drug called Dipta. During preclinical research on...
Researchers from Trinity College Dublin have made an important discovery that may lead to more effective multiple sclerosis (MS) treatments as well as other autoimmune diseases such as psoriasis and rheumatoid arthritis. They are focused on drugs centering on IL-17, a...
GeNeuro, a European biopharmaceutical company developing new treatments, focused on stopping causal factors driving the progression of neurodegenerative and autoimmune disease raised €17.5 million ($19.3 million) international private placement to certain qualified...
Boutique short-seller Kerrisdale Capital Management (KCM), a private investment manager, recently published a report explaining why they have taken a short position in Principia Biopharma Inc. (NASDAQ: PRNB), a biopharma company whose recent $2 billion valuation is...
Case Western Reserve University researchers have developed a drug known as Myeliviz that could make it easier for doctors to diagnose multiple sclerosis (MS) in its earlier stages. The Ohio-based team has secured $1.7 million from the NIH for an FDA-compliant...
